RedHill Biopharma to Host First Quarter 2018 Financial Results Conference Call on May 8, 2018
May 01, 2018 11:01 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., May 01, 2018 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...
Biomica, Evogene’s Newly Established Subsidiary, Announces Therapeutic Areas of Focus
May 01, 2018 11:01 am UTC| Business
REHOVOT, Israel, May 01, 2018 -- Biomica, a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's...
Sonasoft Corp (SSFT) Jointly Signs Purchase Agreement to Acquire Cornerstone Technologies
May 01, 2018 11:01 am UTC| Business
San Jose, California, May 01, 2018 -- Sonasoft Corp. (OTCPK: SSFT), a leader in eDiscovery solutions and business continuity services, announces that it has jointly signed a purchase agreement to acquire Cornerstone...
May 01, 2018 11:01 am UTC| Business
LATHAM, N.Y., May 01, 2018 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, and Workhorse Group, Inc. (NASDAQ:WKHS) an American technology company focused on...
VIVUS Restructures Debt and Gains Access to New Capital
May 01, 2018 11:01 am UTC| Business
Athyrium Capital Management partners with VIVUS to support next growth phase New capital to be used to facilitate the acquisition of PANCREAZE® (pancrelipase) CAMPBELL, Calif. and NEW YORK, May 01, 2018 -- VIVUS,...
Noble Energy Announces First Quarter 2018 Results
May 01, 2018 11:01 am UTC| Business
HOUSTON, May 01, 2018 -- Noble Energy, Inc. (NYSE:NBL) (“Noble Energy” or the "Company”) today announced first quarter 2018 financial and operating results. Highlights include: Delivered quarterly sales volumes...
Axsome Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018
May 01, 2018 11:01 am UTC| Business
Axsome to host conference call and webcast on Tuesday, May 8, 2018 at 8:00 AM Eastern Time NEW YORK, May 01, 2018 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel...